
Diaceutics PLC (DXRX.L)
DXRX.L Stock Price Chart
Explore Diaceutics PLC interactive price chart. Choose custom timeframes to analyze DXRX.L price movements and trends.
DXRX.L Company Profile
Discover essential business fundamentals and corporate details for Diaceutics PLC (DXRX.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
21 Mar 2019
Employees
184.00
Website
https://www.diaceutics.comCEO
Ryan Keeling
Description
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX patient journey that enables pharma customers to complete a longitudinal analysis of biomarker testing journeys of individual patients, which identifies opportunities for earlier testing and treatment; DXRX lab benchmarking that enables laboratories to gain competitive edge and compare key criteria to others in the industry providing metrics, such as disease, testing and methodology, market share, turnaround time, and laboratory leadership in these areas; DXRX test reimbursement, which enables pharma customers to engage with laboratories to fund the introduction of novel companion diagnostics, as well as reducing the lag time in test adoption; and DXRX test signal that delivers a real-time alert of a testing event, which allows pharma customers to identify therapeutically actionable patients in the previous weeks. In addition, it offers diagnostic landscape, planning, implementation, and tracking services; and consulting services for precision medicine diagnostics. Further, the company provides test standardization, test quality assessment, test report optimization, laboratory tech support, test access and reimbursement, laboratory training, and educational resources services. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
DXRX.L Financial Timeline
Browse a chronological timeline of Diaceutics PLC corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 15 Sept 2025
Earnings released on 13 May 2025
EPS came in at £0.01 falling short of the estimated £0.02 by -50.92%, while revenue for the quarter reached £19.84M, missing expectations by -0.24%.
Earnings released on 17 Sept 2024
EPS came in at -£0.03 surpassing the estimated -£0.04 by +19.47%, while revenue for the quarter reached £12.32M, beating expectations by +0.16%.
Earnings released on 21 May 2024
EPS came in at -£0.00 falling short of the estimated £0.00 by -186.11%, while revenue for the quarter reached £13.78M, missing expectations by -0.47%.
Earnings released on 26 Sept 2023
EPS came in at -£0.02, while revenue for the quarter reached £9.92M, beating expectations by +0.24%.
Earnings released on 18 Apr 2023
EPS came in at £0.02 surpassing the estimated £0.01 by +25.21%, while revenue for the quarter reached £11.98M, missing expectations by -4.19%.
Earnings released on 30 Jun 2022
EPS came in at -£0.01, while revenue for the quarter reached £7.53M, beating expectations by +0.37%.
Earnings released on 31 Dec 2021
EPS came in at £0.01 falling short of the estimated £0.01 by -19.16%, while revenue for the quarter reached £7.98M, beating expectations by +4.96%.
Earnings released on 30 Jun 2021
EPS came in at -£0.00, while revenue for the quarter reached £5.97M.
Earnings released on 31 Dec 2020
EPS came in at -£0.01, while revenue for the quarter reached £7.40M.
DXRX.L Stock Performance
Access detailed DXRX.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.